Inspire Trust Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.87M Buy
75,000
+6,000
+9% +$484K 0.81% 51
2026
Q1
$5.98M Buy
69,000
+10,500
+18% +$1.01M 0.92% 45
2025
Q4
$5.62M Buy
58,500
+6,000
+11% +$583K 0.92% 46
2025
Q3
$5M Hold
52,500
– – 0.91% 46
2025
Q2
$4.58M Buy
52,500
+6,500
+14% +$551K 0.94% 43
2025
Q1
$4.13M Buy
46,000
+2,000
+5% +$179K 0.98% 36
2024
Q4
$3.51M Buy
44,000
+7,500
+21% +$649K 0.9% 42
2024
Q3
$3.29M Buy
36,500
+5,993
+20% +$504K 0.91% 40
2024
Q2
$2.4M Buy
30,507
+11,622
+62% +$953K 0.79% 51
2024
Q1
$1.65M Buy
18,885
+8,016
+74% +$684K 0.92% 40
2023
Q4
$895K Buy
+10,869
New +$828K 0.92% 36

Other funds holding MDT

Inspire Trust Company's MDT Position: Q2 2026 in Review

Inspire Trust Company increased its Medtronic (MDT) stake by 8.7% in Q2 2026, buying an estimated $484K and bringing the position to 75,000 shares worth $5.87M. The position accounts for 0.81% of the portfolio, ranked #51.

Inspire Trust Company first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.98M in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Inspire Trust Company held 75,000 shares of Medtronic worth $5.87M as of Q2 2026.
  • Inspire Trust Company bought 6,000 Medtronic shares in Q2 2026, an estimated $484K.
  • Medtronic made up 0.81% of Inspire Trust Company's portfolio in Q2 2026, its #51 holding.
  • Inspire Trust Company first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Inspire Trust Company's Medtronic position peaked at $5.98M in Q1 2026.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Inspire Trust Company's 13F filing for Q2 2026, filed 5 Aug 2026.